Rankings
▼
Calendar
XOMAP Q2 2023 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+68.7% YoY
Gross Profit
$2M
97.6% margin
Operating Income
-$6M
-359.3% margin
Net Income
-$5M
-325.7% margin
EPS (Diluted)
$-0.47
QoQ Revenue Growth
+279.4%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$126M
Total Liabilities
$16M
Stockholders' Equity
$110M
Cash & Equivalents
$31M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$983,000
+68.7%
Gross Profit
$2M
$943,000
+71.7%
Operating Income
-$6M
-$5M
-25.0%
Net Income
-$5M
-$5M
-15.6%
← FY 2023
All Quarters
Q3 2023 →